Interferon‐β‐induced miR‐155 inhibits osteoclast differentiation by targeting SOCS1 and MITF

Authors:
  • HZHongying Zhao
    Hongying Zhao
  • JCJinping Chen
    Jinping Chen
  • BXBing Xia
    Bing Xia
  • YJYongming Jin
    Yongming Jin
  • WWWei Wei
    Wei Wei
  • JSJianjian Shen
    Jianjian Shen
  • YHYazeng Huang
    Yazeng Huang

Abstract
IFN‐β is induced via a c‐fos dependent mechanism that is present downstream of the receptor activator of NF‐κB ligand (RANKL)‐RANK signal transduction cascade during osteoclast differentiation. Increased production of IFN‐β in turn inhibits osteoclastogenesis. However, the mechanism by which IFN‐β exerts its suppressive function remains unclear. In the present study, we found that miR‐155, an IFN‐β‐induced miRNA, mediated the suppressive effect of IFN‐β on osteoclast differentiation by targeting SOCS1 and MITF, two essential regulators of osteoclastogenesis. These findings have not only demonstrated that miR‐155 inhibits osteoclast differentiation, but also provided a new therapeutic target for treatment of osteoclast‐mediated diseases.

This publication has 41 references indexed in Scilit: